Search research articles
Contact Us
Filters
Showing results (21-30 of 56) with videos related to
Page
of 6
Sort By:
Ceskoslovenska Pediatrie
|
December 1, 1978
[Metabolic changes of cholestatic lipoprotein (LP-X) in the diagnosis of biliary atresia]
J R Poley, H N Magnani, P Alaupovic
Thrombosis and Haemostasis
|
January 5, 2005
Treatment of 51 pregnancies with danaparoid because of heparin intolerance
Edelgard Lindhoff-Last, Hans-Joachim Kreutzenbeck, Harry N Magnani
Acta Haematologica
|
March 22, 2006
Safety and efficacy of danaparoid (Orgaran) use in children
Christoph Bidlingmaier, Harry N Magnani, Monika Girisch, et al.
European Journal of Pediatrics
|
January 29, 2000
Heparin-induced thrombocytopenia in paediatric patients--a review of the literature and a new case treated with danaparoid sodium
O Ranze, P Ranze, H N Magnani, et al.
Physical Review Letters
|
December 13, 2006
Hidden order and low-energy excitations in NpO2
P Santini, S Carretta, N Magnani, et al.
Atherosclerosis
|
September 1, 1974
A study of methods of identification and estimation of Lp(a) lipoprotein and of its significance in health, hyperlipidaemia and atherosclerosis
K W Walton, J Hitchens, H N Magnani, et al.
Physical Review Letters
|
June 1, 2004
S mixing and quantum tunneling of the magnetization in molecular nanomagnets
S Carretta, E Liviotti, N Magnani, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal
|
August 11, 2011
Energy levels and emission parameters of the Dy(3+) ion doped into the YPO(4) host lattice
R Faoro, F Moglia, M Tonelli, et al.
Platelets
|
January 1, 1997
Heparin-induced thrombocytopenia: an under-diagnosed syndrome? Proceedings of a workshop held in London on 1 November 1996. Consensus overview
J Amiral, T P Baglin, H N Magnani, et al.
Thrombosis Research
|
March 1, 1987
Early clinical experience of a new heparinoid, Org 10172, in prevention of deep venous thrombosis
J F Cade, M Wood, H N Magnani, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 56) with videos related to
Sort By:
Page
of 6
Ceskoslovenska Pediatrie
|
December 1, 1978
[Metabolic changes of cholestatic lipoprotein (LP-X) in the diagnosis of biliary atresia]
J R Poley, H N Magnani, P Alaupovic
Thrombosis and Haemostasis
|
January 5, 2005
Treatment of 51 pregnancies with danaparoid because of heparin intolerance
Edelgard Lindhoff-Last, Hans-Joachim Kreutzenbeck, Harry N Magnani
Acta Haematologica
|
March 22, 2006
Safety and efficacy of danaparoid (Orgaran) use in children
Christoph Bidlingmaier, Harry N Magnani, Monika Girisch, et al.
European Journal of Pediatrics
|
January 29, 2000
Heparin-induced thrombocytopenia in paediatric patients--a review of the literature and a new case treated with danaparoid sodium
O Ranze, P Ranze, H N Magnani, et al.
Physical Review Letters
|
December 13, 2006
Hidden order and low-energy excitations in NpO2
P Santini, S Carretta, N Magnani, et al.
Atherosclerosis
|
September 1, 1974
A study of methods of identification and estimation of Lp(a) lipoprotein and of its significance in health, hyperlipidaemia and atherosclerosis
K W Walton, J Hitchens, H N Magnani, et al.
Physical Review Letters
|
June 1, 2004
S mixing and quantum tunneling of the magnetization in molecular nanomagnets
S Carretta, E Liviotti, N Magnani, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal
|
August 11, 2011
Energy levels and emission parameters of the Dy(3+) ion doped into the YPO(4) host lattice
R Faoro, F Moglia, M Tonelli, et al.
Platelets
|
January 1, 1997
Heparin-induced thrombocytopenia: an under-diagnosed syndrome? Proceedings of a workshop held in London on 1 November 1996. Consensus overview
J Amiral, T P Baglin, H N Magnani, et al.
Thrombosis Research
|
March 1, 1987
Early clinical experience of a new heparinoid, Org 10172, in prevention of deep venous thrombosis
J F Cade, M Wood, H N Magnani, et al.
Page
of 6